摘要
目的探讨胰高血糖素样肽-1类似物(JC003)对实验性糖尿病血糖和胰岛功能的影响。方法84只Wistar大鼠,采用高脂饮食和注射40 mg/kg链脲佐菌素(STZ)方法建立实验性糖尿病动物模型。JC003治疗14 d后,采用酶化学方法检测空腹血糖;采用放射免疫方法检测血清胰岛素和C肽。胰腺组织切片HE染色和链霉菌抗生物素-过氧化物酶(SABC)免疫组化染色方法对胰岛结构和胰岛素表达情况进行观察。结果JC003中剂量组(10μg/kg)、高剂量组(100μg/kg)与糖尿病模型组比较血糖明显降低(P<0.01);中剂量组(10μg/kg)、高剂量组(100μg/kg)的血清胰岛素和C肽水平明显高于糖尿病模型组(P<0.05);JC003各剂量组对糖尿病大鼠的胰岛组织结构有显著的保护作用,并且可以增加胰岛素表达阳性的β细胞(P<0.01)。结论JC003可以通过保护大鼠胰岛细胞免受STZ的伤害和增加胰岛β细胞数量来增加胰岛素的表达和分泌,从而降低糖尿病动物血糖。
Objective To investigate the therapeutic effects of glucagon-like peptide-1 analog (JC003) on blood glucose and pancreatic functions of diabetes mellitus in rats. Methods A total of 84 Wistar rats were used in this experiment. Diabetes mellitus animal models were induced with high-fat diet and injection of 40 mg/kg streptozotociul (STZ). After 14 d of JC003 therapy, the level of fasting plasma glucose (FPG) was detected with enzyme-chemical method. The level of serum insulin and C-peptide were measured with immunoradiometric assay method. Serial pancreatic sections were made and stained with hematoxylin-eosin (HE) and streptavidin-biotin- peroxidase complex (SABC). Results After 14 d of JC003 injection, the level of FPG in medium-dose group (10 μg/kg) and high-dose group (100μg/kg) was lower than that in diabetes mellitus (DM) group (P〈0.01). The level of serum insulin and C-peptide of medium-dose group (10μg/kg) and high-dose group (100μg/kg) was higher than in DM group (P 〈 0. 05). JC003 could protect pancreatic islet from injury of STZ and increase insulin- expressing positive rate (P〈0.01). Conclusion GLP-1 analog (JC003) can lower the level of blood glucose of diabetes mellitus through protecting pancreatic islet β cells and increasing insulin expression and secretion.
出处
《西安交通大学学报(医学版)》
CAS
CSCD
北大核心
2007年第6期651-654,671,共5页
Journal of Xi’an Jiaotong University(Medical Sciences)
基金
吉林省科技发展重点基金资助项目(20050413-4)
高等学校博士点基金资助项目(2005)